The Fellow on Call: The Heme/Onc Podcast cover image

Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826

The Fellow on Call: The Heme/Onc Podcast

00:00

SWOG 1826: Design, Results, and Implications

Details of the randomized trial comparing nivo+AVD vs BV+AVD: enrollment, 1‑year PFS (94% vs 86%), hazard ratio/p‑value interpretation, toxicity differences (less neuropathy/bone pain with nivo), and future de‑escalation strategies.

Play episode from 07:19
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app